Correlation between increased urinary serotonin levels and coronary artery disease in cigarette smoking patients

Platelets secrete serotonin (5-hydroxytryptamine), which has several effects on the vascular wall and promotes thrombogenesis, mitogenesis, and the proliferation of smooth muscle cells. We therefore measured excreted levels of 5-hydroxytryptamine (5-HT) concentrations in urine as a means of assessing vascular lesions in patients with coronary artery disease ( CAD). Materials and methods: Subjects who underwent coronary angiography were classified into 2 groups according to their diagnosis. The CAD group consisted of 33 patients with coronary artery stenosis, whereas the healthy control group consisted of 30 subjects. An isocratic high-performance liquid chromatographic (HPLC) system with an electrochemical detector was used for the HPLC analysis of serotonin in urine. Results: The mean urine 5-HT concentration was significantly (P < 0.01) higher in CAD patients than in the healthy control patients. Interestingly, the excretion of the urinary 5-HT levels in CAD patients were positively associated with cigarette smoking (r = 0.411, P < 0.01), serum hs-CRP levels (r = 0.198, P < 0.05), and age (r = 0.132, P < 0.05). Conclusion: The increase in the amount of serotonin in urine in correlation with cigarette smoking, age, and hs-CRP may be important for future treatment strategies.

Anahtar Kelimeler:

Key words: Smoking, serotonin, 5-HT, urine, coronary, platelet

Correlation between increased urinary serotonin levels and coronary artery disease in cigarette smoking patients

Keywords:

Key words: Smoking, serotonin, 5-HT, urine, coronary, platelet,

PDF

___

Villazon M, Padin JF, Cadavid MI, Enguix MJ, Tristan H, Orallo F. Functional characterization of serotonin receptors in rat isolated aorta. Biol Pharm Bull 2002, 25: 584-590.
McDuffie E, Coaxum SD, Maleque MA. 5-Hydroxytryptamine evokes endothelial nitric oxide synthase activation in bovine aortic endothelial cell cultures. Proc Soc Exp Biol Med 1999; 221: 386-390.
Morita Y, Takahashi H, Kamihata H, Yamamoto Y, Hara K, Iwasaka T. Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases after spasm provocation tests in patients with coronary spastic angina. Int J Cardiol 2001; 80: 243. 250.
Vanhoutte M. Platelet-derived serotonin, the endothelium, and cardiovascular disease. J Cardiovasc Pharmacol 1991; 17: suppl 5, 6-9.
De Clerck F. Effects of serotonin on platelets and blood vessels. J Cardiovasc Pharmacol 1991; 17: 1-5.
Ishida J, Iizuka R, Yamaguchi M. High-performance liquid chromatographic determination of 5-hydroxyindole by post- column fluorescence derivatization. Analyst 1993; 118: 165-169.
Yilmaz N, Cicek HK, Celik A, Davutoglu V. Diagnostic value of bilirubin concentrations compared with novel and traditional biomarkers in atherosclerosis with coronary artery disease. Saudi Med J 2006; 27: 1262-4.
Hirowatari Y, Hara K, Kamihata H, Iwasaka T, Takahashi H. High-performance liquid chromatographic method with column-switching and post-column reaction for determination of serotonin levels in platelet-poor plasma. Clin Biochem 2004; 37: 191–7.
Venturinelli ML, Hovnan A. Soeiro Ade M, Nicolau JC, Ramires JA, D’Amico EA et al. Platelet activation in different clinical forms of the coronary artery disease (role of P-selectin and others platelet markers in stable and unstable angina). Arq Bras Cardiol 2006; 87: 446-50.